Suppr超能文献

采用胸廓内动脉移植的冠状动脉搭桥手术——15年期间对生存率的影响

Coronary bypass surgery with internal-thoracic-artery grafts--effects on survival over a 15-year period.

作者信息

Cameron A, Davis K B, Green G, Schaff H V

机构信息

Division of Cardiology, St. Luke's-Roosevelt Hospital Center, New York, NY 10025, USA.

出版信息

N Engl J Med. 1996 Jan 25;334(4):216-9. doi: 10.1056/NEJM199601253340402.

Abstract

BACKGROUND

Aortocoronary bypass surgery has been performed most often with the patient's saphenous vein as the conduit. The internal-thoracic-artery graft, which has superior patency rates, has been shown to have clinical advantages, but it is not known how long these advantages persist.

METHODS

We identified all the patients in the registry of the Coronary Artery Surgery Study who had undergone first-time coronary-artery bypass grafting. Those with internal-thoracic-artery bypass grafts (749 patients) were compared with those with saphenous-vein bypass grafts only (4888 patients) with respect to survival over a 15-year follow-up period.

RESULTS

In a multivariate analysis to account for differences between the two groups, the presence of an internal-thoracic-artery graft was an independent predictor of improved survival and was associated with a relative risk of dying of 0.73 (95 percent confidence interval, 0.64 to 0.83). This improved survival was also observed in subgroups including patients 65 years of age or older, both men and women, and patients with impaired ventricular function. The survival curves of the two groups showed further separation over the years of follow-up, with a more marked downsloping after eight years in the curve for the group with saphenous-vein grafts only than in that for the group with internal-thoracic-artery grafts.

CONCLUSIONS

As compared with saphenous-vein coronary bypass grafts, internal-thoracic-artery grafts conferred a survival advantage throughout a 15-year follow-up period. The survival advantage increased with time, suggesting that the initial selection of the conduit was a more important factor in survival than problems appearing long after surgery, such as the progression of coronary disease.

摘要

背景

主动脉冠状动脉搭桥手术最常使用患者的大隐静脉作为管道。胸廓内动脉移植物的通畅率更高,已显示出临床优势,但尚不清楚这些优势能持续多久。

方法

我们在冠状动脉外科研究登记处中识别出所有接受首次冠状动脉搭桥手术的患者。将接受胸廓内动脉搭桥手术的患者(749例)与仅接受大隐静脉搭桥手术的患者(4888例)在15年的随访期内的生存率进行比较。

结果

在一项考虑两组差异的多变量分析中,胸廓内动脉移植物的存在是生存率提高的独立预测因素,与死亡相对风险为0.73相关(95%置信区间,0.64至0.83)。在包括65岁及以上患者、男性和女性以及心室功能受损患者的亚组中也观察到了生存率的提高。两组的生存曲线在随访多年中进一步分离,仅接受大隐静脉移植物组的曲线在8年后比接受胸廓内动脉移植物组的曲线有更明显的下斜。

结论

与大隐静脉冠状动脉搭桥移植物相比,胸廓内动脉移植物在15年的随访期内均赋予了生存优势。生存优势随时间增加,这表明管道的初始选择在生存中比手术后很久出现的问题(如冠状动脉疾病进展)更重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验